$Novo-Nordisk A/S(NVO)$ Close -To The Moon - Tiger Brokers Online Investing Community - To The Moon

$Novo-Nordisk A/S(NVO)$

Close position due to change of opinion on Novo's drug competitiveness.

NVO

08-25 21:52

USNovo-Nordisk A/S

Side	Price \| Filled	Realized P&L
Sell Close	57.78 100	+25.82% Closed

Novo-Nordisk A/S

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
08-25
Trade Feed Decoder
Novo Nordisk's 25.82% realized gain suggests effective execution of a bullish thesis, potentially tied to its leadership in diabetes/obesity treatments. The SELL decision might reflect profit-taking after strong performance or anticipation of sector rotation. While the return is notable, traders could analyze whether position sizing aligned with risk management principles given the stock's historical volatility. This trade exemplifies a momentum-driven approach, though the absence of entry context limits full strategy evaluation. The outcome underscores the interplay between fundamental positioning (e.g., Novo's GLP-1 drug dominance) and tactical exit timing, emphasizing how thematic investing in healthcare innovators can yield substantial returns when paired with disciplined profit realization.
Kristina_
08-26
Kristina_
Good profit on this trade!![Miser][Miser]
glimmero
08-25
glimmero
Great move on the NVO trade! 💪

Leave a comment

3

41

10

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":471420005933544,"tweetId":"471420005933544","gmtCreate":1756130043291,"gmtModify":1756193705804,"author":{"id":3563243258535559,"idStr":"3563243258535559","authorId":3563243258535559,"authorIdStr":"3563243258535559","name":"MKTrader","avatar":"https://static.tigerbbs.com/41fde116200c232379312d26e2768f6e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":13,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.25%","individualDisplayEnabled":0},"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.13","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":897,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":698,"starInvestorOrderShareNum":1178,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":62.51,"showRor":true,"investmentPhilosophy":"Only high quality stocks. Balanced risk management until opportunity arrives, then go big.","winRationPercentage":66.082949,"tradeVolumeEst":0},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/b1d3162f26b9135586bedc124b364b40","width":"906","height":"1459"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/b1d3162f26b9135586bedc124b364b40","width":"906","height":"1459"}],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><p>Close position due to change of opinion on Novo's drug competitiveness.</p><img src=\"https://community-static.tradeup.com/news/b1d3162f26b9135586bedc124b364b40\" tg-width=\"906\" tg-height=\"1459\"></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><p>Close position due to change of opinion on Novo's drug competitiveness.</p><img src=\"https://community-static.tradeup.com/news/b1d3162f26b9135586bedc124b364b40\" tg-width=\"906\" tg-height=\"1459\"></body></html>","text":"$Novo-Nordisk A/S(NVO)$ Close position due to change of opinion on Novo's drug competitiveness.","highlighted":1,"essential":1,"paper":1,"likeSize":41,"commentSize":3,"repostSize":10,"favoriteSize":0,"link":"https://ttm.financial/post/471420005933544","repostId":0,"isVote":1,"tweetType":1,"viewCount":1335,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"3563243258535559","orderId":"40269341097988096","kind":"TRADE","symbol":"NVO","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/NVO","symbolName":"Novo-Nordisk A/S","market":"US","action":"SELL","currency":"USD","symbolLogo":"https://static.tigerbbs.com/4454e2be594d73a2a7bfa9c42bfb69f7","showFilledQuantity":true,"nameCN":"Novo-Nordisk A/S","orderType":"LMT","filledQuantityFinal":100,"avgFillPrice":57.78,"createTime":1756129956,"filledQuantity":"100","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"Novo-Nordisk A/S","contractExtraDescription":"NVO","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":0.2582,"realizedPnlByAveragePercent":0.0199},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":61,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":471446988325040,"commentId":"471446988325040","gmtCreate":1756136743032,"gmtModify":1756136748903,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":471420005933544,"objectIdStr":"471420005933544","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Novo Nordisk's 25.82% realized gain suggests effective execution of a bullish thesis, potentially tied to its leadership in diabetes/obesity treatments. The SELL decision might reflect profit-taking after strong performance or anticipation of sector rotation. While the return is notable, traders could analyze whether position sizing aligned with risk management principles given the stock's historical volatility. This trade exemplifies a momentum-driven approach, though the absence of entry context limits full strategy evaluation. The outcome underscores the interplay between fundamental positioning (e.g., Novo's GLP-1 drug dominance) and tactical exit timing, emphasizing how thematic investing in healthcare innovators can yield substantial returns when paired with disciplined profit realization.","text":"Novo Nordisk's 25.82% realized gain suggests effective execution of a bullish thesis, potentially tied to its leadership in diabetes/obesity treatments. The SELL decision might reflect profit-taking after strong performance or anticipation of sector rotation. While the return is notable, traders could analyze whether position sizing aligned with risk management principles given the stock's historical volatility. This trade exemplifies a momentum-driven approach, though the absence of entry context limits full strategy evaluation. The outcome underscores the interplay between fundamental positioning (e.g., Novo's GLP-1 drug dominance) and tactical exit timing, emphasizing how thematic investing in healthcare innovators can yield substantial returns when paired with disciplined profit realization.","html":"Novo Nordisk's 25.82% realized gain suggests effective execution of a bullish thesis, potentially tied to its leadership in diabetes/obesity treatments. The SELL decision might reflect profit-taking after strong performance or anticipation of sector rotation. While the return is notable, traders could analyze whether position sizing aligned with risk management principles given the stock's historical volatility. This trade exemplifies a momentum-driven approach, though the absence of entry context limits full strategy evaluation. The outcome underscores the interplay between fundamental positioning (e.g., Novo's GLP-1 drug dominance) and tactical exit timing, emphasizing how thematic investing in healthcare innovators can yield substantial returns when paired with disciplined profit realization.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"},{"id":471742976065632,"commentId":"471742976065632","gmtCreate":1756193724216,"gmtModify":1756193728891,"authorId":10000000000010968,"author":{"id":10000000000010968,"idStr":"10000000000010969","authorId":10000000000010968,"name":"Kristina_","avatar":"https://static.tigerbbs.com/390bb094fc9bb64af7414f37cde534ff","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":471420005933544,"objectIdStr":"471420005933544","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Good profit on this trade!!<span class=\"teditor-emoji\">[Miser]</span><span class=\"teditor-emoji\">[Miser]</span>","text":"Good profit on this trade!!<span class=\"teditor-emoji\">[Miser]</span><span class=\"teditor-emoji\">[Miser]</span>","html":"Good profit on this trade!!<span class=\"teditor-emoji\">[Miser]</span><span class=\"teditor-emoji\">[Miser]</span>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":471429247594752,"commentId":"471429247594752","gmtCreate":1756132392495,"gmtModify":1756199714957,"authorId":9000000000000479,"author":{"id":9000000000000479,"idStr":"9000000000000479","authorId":9000000000000479,"name":"glimmero","avatar":"https://static.tigerbbs.com/9e5f3c34ca3b3743623fe1884a908495","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":471420005933544,"objectIdStr":"471420005933544","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Great move on the NVO trade! 💪","text":"Great move on the NVO trade! 💪","html":"Great move on the NVO trade! 💪","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/471420005933544"}